Vanguard Group Inc Biomea Fusion, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,365,625 shares of BMEA stock, worth $6.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,365,625

Previous 1,349,999 1.16%

Holding current value

$6.15 Million

Previous $19.6 Million 4.16%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.92 - $19.5 $217,513 - $304,707	15,626 Added 1.16%	1,365,625 $20.4 Million
Q4 2023 Feb 14, 2024	BUY	$8.37 - $19.8 $88,479 - $209,305	10,571 Added 0.79%	1,349,999 $19.6 Million
Q3 2023 Nov 14, 2023	BUY	$13.44 - $23.02 $293,462 - $502,641	21,835 Added 1.66%	1,339,428 $18.4 Million
Q2 2023 Aug 14, 2023	BUY	$21.66 - $41.8 $4.94 Million - $9.54 Million	228,245 Added 20.95%	1,317,593 $28.9 Million
Q1 2023 May 15, 2023	BUY	$6.8 - $32.35 $1.56 Million - $7.4 Million	228,771 Added 26.58%	1,089,348 $33.8 Million

Q4 2022 Feb 10, 2023	BUY	$6.3 - $11.6 $361,991 - $666,524	57,459 Added 7.15%	860,577 $7.25 Million
Q3 2022 Nov 14, 2022	BUY	$9.51 - $13.61 $1.19 Million - $1.71 Million	125,311 Added 18.49%	803,118 $7.85 Million
Q2 2022 Aug 12, 2022	SELL	$3.0 - $12.03 $260,958 - $1.05 Million	-86,986 Reduced 11.37%	677,807 $8.12 Million
Q1 2022 May 13, 2022	BUY	$4.39 - $9.03 $333,389 - $685,765	75,943 Added 11.02%	764,793 $3.41 Million
Q4 2021 Feb 14, 2022	BUY	$7.22 - $12.72 $1.41 Million - $2.48 Million	194,759 Added 39.42%	688,850 $5.13 Million
Q3 2021 Nov 12, 2021	BUY	$10.0 - $15.99 $1.67 Million - $2.66 Million	166,616 Added 50.88%	494,091 $5.92 Million
Q2 2021 Aug 13, 2021	BUY	$13.65 - $20.93 $4.47 Million - $6.85 Million	327,475 New	327,475 $5.11 Million

Others Institutions Holding BMEA

# of Institutions

121

Shares Held

25.7M

Call Options Held

2.56M

Put Options Held

879K

View Full List

About Biomea Fusion, Inc.

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $132M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

More about BMEA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Biomea Fusion, Inc. Transaction History